Aclaris Therapeutics, Inc. (LON:0H8T)
London
· Delayed Price · Currency is GBP · Price in USD 1.270
+0.031 (2.49%)
At close: May 16, 2025
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 109.35 million as of May 20, 2025. Its market cap has increased by 41.60% in one year.
Market Cap
109.35M
Enterprise Value
-31.31M
Revenue
13.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.27
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has decreased from 140.05M to 109.35M, a decrease of -21.92%. That is a compound annual growth rate of -2.54%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.83B |
| GSK plc | 56.70B |
| Haleon | 36.56B |
| Smith & Nephew | 9.51B |
| ConvaTec Group | 5.57B |
| Hikma Pharmaceuticals | 4.56B |
| HUTCHMED (China) | 1.76B |
| Genus | 1.38B |